{"id":"nct:NCT05929079","kind":"trial","title":"A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight","authors":["Eli Lilly and Company"],"author_count":1,"year":2023,"published":"2023-07-03","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT05929079","source_url":"https://clinicaltrials.gov/study/NCT05929079","archive_url":"https://space-kitty.com/papers/nct:NCT05929079","updated":null,"pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":null,"abstract_license":null,"license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":[],"details":{"status":"COMPLETED","phase":"PHASE3","start_date":"2023-07-11","start_date_type":"ACTUAL","data_source":"ClinicalTrials.gov","data_processed":"2026-10-30","modifications":"selected fields only (title, sponsor, status, phase, dates); reformatted"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-30; modifications: selected fields only (title, sponsor, status, phase, dates); reformatted. Not a U.S. Government endorsement.","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}